Cipro’s Safety Warnings Just Got Scarier – by Beth Skwarecki – July 2018
The “mental health effects” can be especially disturbing (who would think to blame an antibiotic for paralyzing anxiety?) and especially with EDS, this antibiotic can lead to tendon rupture.
fluoroquinolone antibiotics—a chemical family that includes ciprofloxacin, or Cipro—have been recognized as carrying several different kinds of serious risks, with the most recent warnings issued just yesterday.
Cipro and friends can cause blood sugar to dip low enough to put a person into a coma, and these antibiotics can also cause “mental health side effects” including agitation, memory and attention problems, and a type of serious mental disturbance called delirium. Continue reading
8 things we now know about the toxicity of gadolinium to the brain – The Neurology Lounge – May 26, 2018 – Ibrahim Imam
When it comes to imaging the nervous system, nothing but an MRI will do for the fastidious neurologist.
CT has its uses, such as in detecting acute intracranial bleeding, but it lacks the sophistication to detect or differentiate between less glaring abnormalities. It also comes with a hefty radiation dose.
MRI on the other hand, relying on powerful magnetic fields, is a ‘cleaner’ technology. Continue reading
One shot may block chemo pain for several weeks – By Catharine Paddock PhD – May 2018
It might be possible to relieve the persistent pain that can follow chemotherapy with a natural protein that blocks the underlying inflammation process in cells.
This was the conclusion of new research that tested the effects of a protein, called apolipoprotein A-I binding protein (AIBP), in mice with chemotherapy-induced pain.
Should the approach prove to be effective in humans with chemotherapy pain, it could offer an alternative to opioids, which carry the risk of addiction. Continue reading
The New Drug for Migraines Has Some Drawbacks – Beth Skwarecki – May 2018
Ms. Skwarecki points out that, while some patients responded extremely well, the drug may not be effective at all for another sizeable cohort of patients.
The FDA just approved a new, first-of-its-kind drug intended to prevent migraines.
It comes in an auto-injector device (you stab yourself once a month) at a list price of $575 a pop.Meanwhile, people on r/migraine are saying it isn’t much more expensive than the other drugs they already take. Continue reading
Prescription Drug Dispensing Errors Kill 100,000 People Per Year In US « CBS Sacramento
I wonder if these 100,000 are part of the 440,000 deaths from medical errors in the U.S.
A study from 2016 reveals that each year preventable adverse events (PAEs) lead to the death of 210,000-400,000 patients who seek care at a hospital.
Those figures would make medical errors the third leading cause of death behind heart disease and cancer, according to Centers for Disease Control and Prevention statistics. Continue reading
Dextromethorphan Studied for Use In Bipolar Disorder – May 2018
- Changes in inflammatory cytokines, and
- dysfunction of the neurotrophic system
are thought to be involved in the pathology of bipolar disorder.
Dextromethorphan (DM) has been reported to have
- neuroprotection on dopaminergic neurons, and
- protective effect against inflammation-related neuron damage
Questions Raised About Study Of Device To Ease Opioid Withdrawal– May 2, 2018 – NPR – by Jake Harper
The financial sharks are attracted to the “opioid crisis” (we are merely chum in the waters), seeing in it an opportunity to make huge profits.
Becuase there is no real science involved in determining who needs addiction-treatment, they can sell anything that seems to be even a little bit effective.
To the untrained, the evidence looks promising for a new medical device to ease opioid withdrawal. A small study shows that people feel better when the device, an electronic nerve stimulator called the Bridge, is placed behind their ear. Continue reading
What about all the patients already on opioids? By Karen Shakerdge – APR 9, 2018
As more and more efforts are made across the country to curtail opioid addiction, some say a culture of fear has developed in the medical community — fear for patients’ safety, fear of being prosecuted by regulators.
I haven’t heard of any doctor tapering opioids because they are concerned about their “patients’ safety” but I’ve read of many doctors afraid of being accused and prosecuted for prescribing “too much”. Continue reading
Here are excerpts from several articles that investigate the effects of antiepileptics, like gabapentin (Neurontin) and pregabalin (Lyrica), which are increasingly prescribed for pain simply because they are not opioids.
This is a followup from a previous post: Some antiepileptic drugs increase risk of dementia.
Adverse cognitive effect of gabapentin [Neurontin] in individuals with spinal cord injury: preliminary findings. – PubMed – NCBI – Spinal Cord Ser Cases. 2018 Jan Continue reading
Antiepileptic drugs increase risk of Alzheimer’s and dementia – Science Daily – April 2018 – University of Eastern Finland
The use of [some] antiepileptic drugs is associated with an increased risk of Alzheimer’s disease and dementia, according to a new study from the University of Eastern Finland and the German Center for Neurodegenerative Diseases, DZNE.
Continuous use of antiepileptic drugs for a period exceeding one year was associated with a 15 percent increased risk of Alzheimer’s disease in the Finnish dataset, and with a 30 percent increased risk of dementia in the German dataset.
This is the class of drugs we are being coerced to take instead of opioids despite the fact that opioids have far fewer side effects. Continue reading